In vitro and in vivo evaluation of puerarin-loaded PEGylated mesoporous silica nanoparticles

References

• State pharmacopeia Commission of P.R. China. Pharmacopoeia of the People's Republic of China. Vol. 2. Beijing: China Medical Science Press; 2015.
   Google Scholar
• Jiang L, Dai J, Huang Z, et al. Simultaneous determination of gastrodin and puerarin in rat plasma by HPLC and the application to their interaction on pharmacokinetics. J Chromatogr B 2013;915–916:8–12.
   PubMed Web of Science ®Google Scholar
• Luo CF, Yuan M, Chen MS, et al. Determination of puerarin in rat plasma by rapid resolution liquid chromatography tandem mass spectrometry in positive ionization mode. J Chromatogr B 2011;879:1497–501.
   PubMed Web of Science ®Google Scholar
• Luo CF, Yuan M, Chen MS, et al. Pharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administration. Int J Pharm 2011;410:138–44.
   PubMed Web of Science ®Google Scholar
• Hou SZ, Li G, Lai XP, et al. Experimental studies on mechanism of hemolysis induced by puerarin injection. ADRJ 2008;10:1–6.
   Google Scholar
• Hou SZ, Su ZR, Chen SX, et al. Role of the interaction between puerarin and the erythrocyte membrane in puerarin-induced hemolysis. Chem Biol Interact 2011;192:184–92.
   PubMed Web of Science ®Google Scholar
• Jia L, Shen J, Li Z, et al. In vitro and in vivo evaluation of paclitaxel-loaded mesoporous silica nanoparticles with three pore sizes. Int J Pharm 2013;445:12–19.
   PubMed Web of Science ®Google Scholar
• Fu T, Lu J, Guo L, et al. Improving bioavailability of silybin by inclusion into SBA-15 mesoporous silica materials. J Nanosci Nanotechnol 2012;12:3997–4006.
   PubMed Web of Science ®Google Scholar
• Li L, Huang X, Liu T, et al. Overcoming multidrug resistance with mesoporous silica nanorods as nanocarrier of doxorubicin. J Nanosci Nanotechnol 2012;12:4458–66.
   PubMed Web of Science ®Google Scholar
• Moon DS, Lee JK. Tunable synthesis of hierarchical mesoporous silica nanoparticles with radial wrinkle structure. Langmuir 2012;28:12341–7.
   PubMed Web of Science ®Google Scholar
• Song B, Wu C, Chang J. Controllable delivery of hydrophilic and hydrophobic drugs from electrospun poly(lactic-co-glycolic acid)/mesoporous silica nanoparticles composite mats. J Biomed Mater Res B Appl Biomater 2012;100:2178–86.
   PubMed Web of Science ®Google Scholar
• Gu JL, Su SS, Zhu MJ, et al. Targeted doxorubicin delivery to liver cancer cells by PEGylated mesoporous silica nanoparticles with a pH-dependent release profile. Microporous Mesoporous Mater 2012;161:160–7.
   Web of Science ®Google Scholar
• Vivero-Escoto JL, Slowing II, Lin VS. Tuning the cellular uptake and cytotoxicity properties of oligonucleotide intercalator-functionalized mesoporous silica nanoparticles with human cervical cancer cells HeLa. Biomaterials 2010;31:1325–33.
   PubMed Web of Science ®Google Scholar
• Pirollo KF, Chang EH. Does a targeting ligand influence nanoparticle tumor localization or uptake? Trends Biotechnol 2008;26:552–8.
   PubMed Web of Science ®Google Scholar
• Veronese FM, Pasut G. PEGylation, successful approach to drug delivery. Drug Discovery Today 2005;10:1451–8.
   PubMed Web of Science ®Google Scholar
• Hamidi M, Azadi A, Rafiei P. Pharmacokinetic consequences of pegylation. Drug Deliv 2006;13:399–409.
   PubMed Web of Science ®Google Scholar
• Wang XJ, Yang CP, Wang CH, et al. Polymeric micelles with α-glutamyl-terminated PEG shells show low non-specific protein adsorption and aprolonged in vivo circulation time. Mater Sci Eng C Mater Biol Appl 2016;59:766–72.
   PubMed Web of Science ®Google Scholar
• Novikov BN, Grimsley JK, Kern RJ, et al. Improved pharmacokinetics and immunogenicity profile of organophosphorus hydrolase by chemical modification with polyethylene glycol. J Control Release 2010;146:318–25.
   PubMed Web of Science ®Google Scholar
• Zhai Y, Zhao Y, Lei J, et al. Enhanced circulation half-life of site-specific PEGylated rhG-CSF: optimization of PEG molecular weight. J Biotechnol 2009;142:259–66.
   PubMed Web of Science ®Google Scholar
• Lazarjani HA, Vasheghani-Farahani E, Barani L, et al. Effect of polymer concentration on camouflaging of pancreatic islets with mPEG-succinimidyl carbonate. Artif Cells Blood Substit Immobil Biotechnol 2010;38:250–8.
   PubMed Web of Science ®Google Scholar
• Dai L, Li J, Zhang B, et al. Redox-responsive nanocarrier based on heparin end-capped mesoporous silica nanoparticles for targeted tumor therapy in vitro and in vivo. Langmuir 2014;30:7867–77.
   PubMed Web of Science ®Google Scholar
• Lin YC, Lin LY, Gao MY, et al. Mesoporous silica nanoparticles synthesized from liquid crystal display manufacturing extracts as a potential candidate for a drug delivery carrier: evaluation of their safety and biocompatibility. Int J Nanomedicine 2013;8:3833–42.
   PubMedGoogle Scholar
• Wang Y, Sun L, Jiang T, et al. The investigation of MCM-48-type and MCM-41-type mesoporous silica as oral solid dispersion carriers for water insoluble cilostazol. Drug Dev Ind Pharm 2014;40:819–28.
   PubMed Web of Science ®Google Scholar
• Xi J, Qin J, Fan L. Chondroitin sulfate functionalized mesostructured silica nanoparticles as biocompatible carriers for drug delivery. Int J Nanomedicine 2012;7:5235–47.
   PubMed Web of Science ®Google Scholar
• Cui Y, Dong H, Cai X, et al. Mesoporous silica nanoparticles capped with disulfide-linked PEG gatekeepers for glutathione-mediated controlled release. ACS Appl Mater Interfaces 2012;4:3177–83.
   PubMed Web of Science ®Google Scholar
• Liu X, Yu B, Wang N, et al. A validated stability-indicating HPLC method for the determination of PEGylated puerarin in aqueous solutions. J Chromatogr B 2010;878:2061–6.
   PubMed Web of Science ®Google Scholar
• Feng W, Nie W, He C, et al. Effect of pH-responsive alginate/chitosan multilayers coating on delivery efficiency, cellular uptake and biodistribution of mesoporous silica nanoparticles based nanocarriers. ACS Appl Mater Interfaces 2014;6:8447–60.
   PubMed Web of Science ®Google Scholar
• Wang HJ, Zhao PQ, Liang XF, et al. Folate-PEG coated cationic modifie chitosan–cholesterol liposomes for tumor-targeted drug delivery. Biomaterials 2010;31:4129–38.
   PubMed Web of Science ®Google Scholar
• Cauda V, Argyo C, Bein T. Impact of different PEGylation patterns on the long-term bio-stability of colloidal mesoporous silica nanoparticles. J Mater Chem 2010;20:8693–9.
   Web of Science ®Google Scholar
• Lin YS, Haynes CL. Impacts of mesoporous silica nanoparticle size, pore ordering, and pore integrity on hemolytic activity. J Am Chem Soc 2010;132:4834–42.
   PubMed Web of Science ®Google Scholar
• Manjunath K, Venkateswarlu V. Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration. J Control Release 2005;107:215–28.
   PubMed Web of Science ®Google Scholar
• He Q, Zhang Z, Gao F, et al. In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation. Small 2011;7:271–80.
   PubMed Web of Science ®Google Scholar
• Xia T, Kovochich M, Liong M, et al. Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs. ACS Nano 2009;3:3273–86.
   PubMed Web of Science ®Google Scholar
• Meng H, Xue M, Xia T, et al. Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model. ACS Nano 2011;5:4131–44.
   PubMed Web of Science ®Google Scholar